Belgium· BE-AMP-SAM666245-00
Adstiladrin 3 10*11 vp/ml
A nadofaragene firadenovec product containing nadofaragene firadenovec, registered in Belgium by Ferring Pharmaceuticals. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Nadofaragene firadenovec is registered in 7 of 19 countries.
Countries holding a registration under ATC L01XL10 (nadofaragene firadenovec), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Nadofaragene firadenovec · ATC L01XL10
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Nadofaragene Firadenovec
- Manufacturer
- Ferring Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- L01XL10
- ATC class
- Nadofaragene firadenovec
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nadofaragene firadenovec in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADSTILADRINFerring Pharmaceuticals A/S, Kastrup
- FinlandADSTILADRINFerring Pharmaceuticals A/S
- NetherlandsADSTILADRIN 3 × 1011 virusdeeltjes/ml intravesicale suspensieFerring Pharmaceuticals A/S
- PolandAdstiladrinFerring Pharmaceuticals A/S
- SwedenADSTILADRIN 3 x 10E11 vp/ml Intravesikal suspensionFerring Pharmaceuticals A/S
- United StatesADSTILADRINFerring Pharmaceuticals Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Adstiladrin
- Liechtenstein · Adstiladrin
- Norway · Adstiladrin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2f51cbc-17d7-456f-9d82-f9ccf3187e12 GET /v1/drugs/d2f51cbc-17d7-456f-9d82-f9ccf3187e12?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Intravesical suspension",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Adstiladrin 3 10*11 vp/ml",
"name_fr": "Adstiladrin 3 10*11 vp/ml",
"name_nl": "Adstiladrin 3 10*11 vp/ml",
"amp_code": "SAM666245-00",
"strengths": [
"3.0000",
"3.0000",
"9.6000"
],
"pack_count": 1,
"substances": [
"Nadofaragene Firadenovec",
"Glycerol",
"Hydroxypropylbetadex",
"Sodium Dihydrogen Phosphate Dihydrate",
"Sucrose",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Nadofaragene Firadenovec",
"authorisation_numbers": [
"EU/1/26/2035/001"
]
}See everything about nadofaragene firadenovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.